The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients.

Zaltzman, Alina S R; Glick, Lauren A; Zaltzman, Jeffrey S; Nash, Michelle; Huang, Michael; Prasad, G V Ramesh.

Afiliação

Zaltzman AS; Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Glick LA; Faculty of Medicine, University of Toronto, Toronto, Canada.
Zaltzman JS; Division of Nephology and Transplant, Department of Medicine, St. Michael's Hospital, Li-Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada.
Nash M; Renal Transplant Program, St. Michael's Hospital, Toronto, Canada.
Huang M; Renal Transplant Program, St. Michael's Hospital, Toronto, Canada.
Prasad GV; Division of Nephology and Transplant, Department of Medicine, St. Michael's Hospital, Li-Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada.

Transplant Res ; 5: 2, 2016.

Article em En | MEDLINE | ID: mdl-26823971

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article